Here are what the editors at HealthDay consider to be the most important developments in Radiology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Comorbid Neck Injury Up for Women With Concussion
MONDAY, Jan. 28, 2019 (HealthDay News) — Female patients with a concussion-related emergency department visit have an increased risk for comorbid neck injury, according to a study published online Dec. 28 in the Journal of Women’s Health.
Report IDs Areas Lacking Good Practice in Health Tech Assessment
FRIDAY, Jan. 25, 2019 (HealthDay News) — In a report published in the January issue of Value in Health, an ISPOR–The Professional Society for Health Economics and Outcomes Research working group indicates the lack of good practices in three areas of health technology assessment (HTA).
BP >120/80 mm Hg Linked to Lower Gray Matter Volume
THURSDAY, Jan. 24, 2019 (HealthDay News) — In young adults, lower gray matter volume (GMV) is seen in individuals with blood pressure (BP) >120/80 mm Hg, according to a study published online Jan. 23 in Neurology.
Artificial Intelligence System Can Triage Chest Radiographs
WEDNESDAY, Jan. 23, 2019 (HealthDay News) — An artificial intelligence (AI) system based on deep convolutional neural networks (CNN) can accurately detect normal chest radiographs, according to a study published online Jan. 22 in Radiology.
Heberden’s Nodes in Fingers Tied to Knee Osteoarthritis
TUESDAY, Jan. 22, 2019 (HealthDay News) — The presence of Heberden’s nodes (HNs) in finger joints may also indicate structural damage associated with knee osteoarthritis, according to a study published online Jan. 9 in Arthritis & Rheumatology.
Radiographic Knee Osteoarthritis Tied to Increased Risk for Death
FRIDAY, Jan. 18, 2019 (HealthDay News) — Radiographic knee osteoarthritis (RKOA) is associated with an increased risk for mortality from cardiovascular disease (CVD), diabetes, and renal diseases, but self-reported OA is not, according to a study published in the December issue of the International Journal of Epidemiology.
FDA Down to 5 Weeks of Funding to Review New Drug Applications
THURSDAY, Jan. 17, 2019 (HealthDay News) — Due to the federal government shutdown, the U.S. Food and Drug Administration has only about five weeks of funding left to review new drug applications, according to Commissioner Scott Gottlieb, M.D.
Adoption of Advanced Health IT Capabilities Inconsistent